EVELIN CAROLINE DA SILVA
4 resultados
Resultados de Busca
Agora exibindo 1 - 4 de 4
Dissertação IPEN-doc 25954 Análise do perfil de expressão proteica da linhagem celular humana de adenocarcinoma renal, 786-O, submetida à radiação ionizante2018 - SILVA, EVELIN C.daO carcinoma de células renais (CCR) representa 3% das neoplasias humanas e aproximadamente 90% das neoplasias renais e entre os tumores urológicos. O CCR é bastante resistente à radioterapia convencional. Entretanto, com o aparecimento de novas técnicas/equipamentos é possivel a aplicação de doses com precisão presevando-se os tecidos adjacentes. Para a verificação da expressão proteica em diferentes tecidos e fluidos corporais, foi utilizado o estudo proteômico sob diferentes condições e / ou tempos. A espectrometria de massa permite a identificação e quantificação de milhares de proteínas e peptídeos em fluidos biológicos ou células lisadas, sendo assim uma ferramenta poderosa para identificação de potenciais biomarcadores de doenças. A finalidade deste trabalho foi analisar o perfil proteico das células de adenocarcinoma renal (786-0) após a radiação com doses que variaram de 2 a 10 Gy. Os dados foram tratados com o programa One-way ANOVA seguida do de Bonferroni. Pelo ensaio de clonogenicidade definiou-se a dose de 8 Gy como a ideal estudos. A extração das proteínas citoplasmáticas foi realizada com o kit de extração do proteoma subcelular PE e a quantificação das proteínas feita pelo método de Lowry. A integridade das proteínas foi analisada por SDS-PAGE e a solução proteica foi verificada em LTQ Orbitrap. Os resultados gerados foram analisados pelo servidor MASCOT para a busca de peptídeos. A análise por espectrometria de massa foi possível identificar 44 proteínas nas amostras não irradiadas - e 87 das amostras irradiadas. Nas amostras não irradiadas a distribuição dos grupos funcionais foi de síntese proteica 46,66%; Metabolismo energético 16,66%; Migração e proliferação 16,66%; Antioxidantes 3,33%. No grupo irradiado síntese proteica 35,89%; Metabolismo energético 20,51%; Migração e proliferação 20,51%; Antioxidantes 5,12%; Chaperonas moleculares 5,12% e Endopeptidases 5,12%. Em seguida, analisou-se o espetro de as sequências com escores acima de 40. Nas amostras irradiadas encontrou-se: ENO1 (47 kDa); A VIM (53 kDa)/ HEL113; PSMA1; TRAJ56; hCG; Cofilina-1 (19 kDa); HIST1H4H; PKM2; ANXA1; HSPB1/ HSP27. Deste grupo, entendemos que a subunidade alfa do proteassoma - tipo 1 (PSMA1), que possui uma atividade molecular de endopeptidase, seja um alvo interessante para estudos posteriores.Resumo IPEN-doc 24635 Upregulation of peroxideroxin-6 in human renal adenocarcinoma cells 786-0, after ionizing radiation2017 - SILVA, EVELIN C. da; BELLINI, MARIA H.Introduction: Renal cell carcinoma (RCC) accounts for 3% of human malignancies and approximately 90% of renal malignancies and among urological tumors. RCC is quite resistant to conventional radiotherapy. This technique allows the dose of radiation, in a single fraction, to be precisely applied to the tumor and the tissues adjacent to it, most of the time, are spared. Proteomics has allowed large-scale studies of protein expression in different tissues and body fluids, under different conditions and / or times. Mass spectrometry allows the identification and quantification of thousands of proteins and peptides in a biological fluid or lysed cells, and is analyzed on a platform to identify differences in the expression of proteins associated with cancer cell proliferation and to establish potential biomarkers predictive of the response therapy. The peroxideroxin- 6 (PRDX 6) protein encoded by this gene is a member of the antioxidant protein family. The PRDX family contains six members that function in detoxifying ROS and providing cytoprotection from internal and It may play a role in the regulation of phospholipid turnover as well as in protection against oxidative injury. Aim: To analyze the expression of PRDX6 in 786-0 cells, after radiation. Methods: A cell culture of the 786-0 cells was performed and to evaluate the mitotic potential, the clonogenic assay was performed with doses of 2 to 10 Gy irradiated in GammaCell (CTR, IPEN) and incubated for 10 days in normoxia conditions. After 10 days, the colonies of the respective doses were stained with methanol 20% and crystal violet 0,5% and counted, and the multiple comparisons was analized by One-way ANOVA followed by Bonferroni´s test and at the defined dose the cells were irradiated and the cytoplasmic proteins were extracted by the PE kit Subcellular proteome extraction (Merck, USA), dosed by the Lowry method and stored at -20º. For the qualitative analysis of proteins, SDS-PAGE was performed with 50ug of protein and the protein band obtained was digested and analyzed by nanoUPLC tandem nanoESI-MSE mass spectrometry in the LNBio laboratory in Campinas-SP. The generated result was analyzed by MASCOT server for peptides searchs and quantitatively analized by scaffoldTM 4.6 software. Results: After the clonogenic assay was performed, 8 Gy was defined as the dose for cell irradiation, an average protein yield of 786-0 non-irradiated 2,59± 0,07 mg/mL and 786-0 irradiated with 3,13± 0,67 mg/mL was obtained. Mass spectrometry revealed the presence of the PRDX6 protein with a 95% coverage and a fold-change of 3.1 compared to the non-irradiated group. Conclusion: The overexpression of PRDX6 after radiation, suggests a potential role for PRDX6 in protection against oxidative stress and a radioresistance to renal cells,Artigo IPEN-doc 23192 Avaliação da atividade citotóxica dos extratos etanólicos da casca e das folhas da Terminalia fagifolia Mart. sobre células normais e tumorais2017 - RODRIGUES, PATRICIA S. de M.; BERTOLIN, APARECIDO O.; FUCASE, TAMARA M.; GALLUZZI, FERNANDA M.; SILVA, EVELLIN C.; MARUMO, MARIA H.B.Introdução: A procura por novas alternativas terapêuticas, como as que utilizam as plantas medicinais, tem despertado grande interesse da comunidade científica na busca por tratamentos mais eficientes para as doenças, incluindo o câncer. Terminalia fagifolia Mart. é uma planta medicinal encontrada no Cerrado brasileiro, usada popularmente no tratamento de aftas e tumores. Objetivos: Avaliar a atividade citotóxica dos extratos etanólicos da casca e das folhas da Terminalia fagifolia em linhagens celulares NIH 3T3 e L929 e tumorais PC3 e B16F10. Métodos: Foi realizada a metodologia de determinação da viabilidade celular em ensaio com monocamada de células utilizando o ensaio MTS. As linhagens NIH 3T3, L929, PC3 e B16F10 foram expostas por 24 horas a diferentes concentrações dos extratos etanólicos da casca e folhas da Terminalia fagifolia. Resultados: Os resultados adquiridos mostraram que os extratos apresentaram viabilidade celular, sendo considerada de moderada a alta, para as células normais NIH 3T3 e L929 e citotoxicidade severa para as células tumorais PC3 e B16F10. Dessa forma, torna-se necessária a continuidade dos estudos com essa planta, pois os extratos da casca e das folhas apresentaram atividades antitumorais muito promissoras. Conclusões: Os extratos da casca e das folhas demonstraram viabilidade celular ≥ 50% nas linhagens celulares normais NIH 3T3 e L929 e demonstraram atividade citotóxica para as linhagens tumorais PC3 e B16F10, apresentando redução da viabilidade celular em torno de 60% e 70%, respectivamente.Artigo IPEN-doc 21265 Expression of genes involved in porphyrin biosynthesis pathway in the human renal cell carcinoma2015 - ROCHA FILHO, HUGO N. da; SILVA, EVELIN C. da; SILVA, FLAVIA R.O.; COURROL, LILIA C.; MESQUITA, CARLOS H. de; BELLINI, MARIA H.Renal cell carcinoma (RCC) remains one of the greatest challenges of urological oncology and is the third leading cause of death in genitourinary cancers. Surgery may be curative when patients present with localized disease. Our previous results demonstrated the autofluorescence of blood PpIX in primary RCC mouse model and an increase in fluorescence intensity as a function of growth of the subcutaneous tumor mass. In another work, a nice correlation between the growth of the tumor mass and tissue fluorescence intensity was found. The aim of this study was to evaluate the expression profile of porphyrin biosynthesis pathway-related genes of human kidney cells. We used two kidney cell lines, one normal (HK2) and another malignant (Caki-1). Endogenous and 5-aminolevolinic acid (ALA) induced protoporphyrin IX (PpIX) HK2 and Caki-1 cells were analyzed by fluorescence spectroscopy. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to measure mRNA of those genes. Emission spectra were obtained by exciting the samples at 405 nm. For ALA untreated cells the maximum fluorescence intensity was detected at 635 nm. The mean peak area of emission spectra in both cells types increased linearly in function of cell number. Besides, basal levels of PpIX autofluorescence of each cell concentration of HK2 samples were significantly lower than those of Caki-1 samples. For ALA-treated cells the mean PpIX spectra shows PpIX emission peak at 635 nm with a shoulder at 700 nm. Analysis of PpIX fluorescence intensity ratio between tumor cells and HK2 cells showed that fluorescence intensity was, on average, 26 times greater in tumor cells than in healthy cells. qRT-PCR revealed that in Caki-1 ALA-treated cells, PEPT gene was significantly up-regulated and FECH and HO-1 genes were significantly down regulated in comparison with HK2 ALAtreated cells. In conclusion, our results demonstrate the preferential accumulation of ALA-induced PpIX in human RCC and also indicate that PEPT1, FECH and HO-1 genes are major contributors to this accumulation.